Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, has obtained a State Food and Drug Administration (SFDA) import license approval to deliver its preservative-
free multi-dose systems to customers in China.
Sartorius Stedim Biotech launches a new single-use harvesting technology for high cell density cultures up to 2,000L.
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, presents a new scientific white paper, following its recent roundtable held in Paris, France.
PRA Health Sciences, Inc. reported its financial results for the fourth quarter ended December 31, 2014.
PRA Health Sciences (PRA) is enhancing its global Phase I patient strategy and increasing its clinical footprint with the expansion of its Early Development Services (EDS). These initiatives are being undertaken in response to market demand to include patients as early as possible in early phase clinical trial development and include:
Vetter, a leading contract development and manufacturing organization that specializes in aseptic manufacturing, today announced that the company’s Advisory Board unanimously appointed Oliver Albrecht as a new Managing Director effective April 1, 2015. Albrecht replaces Max Horn as a Vetter Managing Director who left the company in June 2014.
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products has partnered with Shanghai Sine Promod Pharmaceutical Co., Ltd. to develop and launch its new Budesonide DPI (Dry Powder Inhaler), which uses Aptar Pharma’s novel, user-friendly and cost-effective Twister® Dry Powder Inhaler.
Aptar pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products has partnered with shanghai sine promod pharmaceutical Co., Ltd. to develop and launch its new Budesonide DPI (Dry powder inhaler), which uses Aptar pharma’s novel, user-friendly and cost-effective Twister® Dry powder inhaler.
Looking at MEDELPHARM Process technologies and ADVANTEST Terahertz spectroscopy analysis systems.
Bruker Corporation today announced the launch of the new BRAVO handheld Raman spectrometer for identification of raw materials. The new BRAVO (Bruker RAman Verification Optics) complements Bruker’s Raman product range, featuring amongst others an innovative fluorescence mitigation, intuitive graphical user interface and a superior guided work-flow. Due to its unique optical design BRAVO is the only handheld Raman spectrometer that is certified as class 1M Laser product.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.